Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026)
Jushi Holdings (JUSHF) reported Cash from Financing Activities of $11.1 million for Q1 2026, up 228.4% year-over-year from $3.4 million in Q1 2025, and up 540.69% quarter-over-quarter from -$2.5 million in Q4 2025.
Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cash from Financing Activities data on file, last reported at $11.1 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $11.1 million, up 228.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (up 158.31% YoY), and the FY2025 annual result was $767000.0, up 103.14% from the prior year.
- Cash from Financing Activities advanced to $11.1 million in Q1 2026 per JUSHF's latest filing, from -$2.5 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $20.1 million in Q2 2023 and troughed at -$13.7 million in Q3 2024.
- A 5-year average of $2.1 million and a median of -$262000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities sank 4971.21% in 2023, then surged 228.4% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at -$2.1 million in 2022, then plunged by 59.51% to -$3.3 million in 2023, then jumped by 56.86% to -$1.4 million in 2024, then tumbled by 74.91% to -$2.5 million in 2025, then soared by 540.69% to $11.1 million in 2026.
- Business Quant data shows JUSHF's Cash from Financing Activities at $11.1 million in Q1 2026, -$2.5 million in Q4 2025, and $166000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 11.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.12 Mn |
| Mar 31, 2026 | 11.12 Mn |
| Dec 31, 2025 | -2.52 Mn |
| Dec 31, 2025 | -2.52 Mn |
| Sep 30, 2025 | 166,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | -262,000.00 |
| Jun 30, 2025 | -262,000.00 |
| Mar 31, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.39 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | -13.74 Mn |
| Sep 30, 2024 | -13.74 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -6.49 Mn |
| Mar 31, 2024 | -6.49 Mn |
| Dec 31, 2023 | -3.35 Mn |
| Dec 31, 2023 | -3.35 Mn |